edicotinib
Showing 1 - 1 of 1
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Portland (Edicotinib, Pharmacokinetic Study)
Terminated
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Edicotinib
- Pharmacokinetic Study
-
Portland, OregonOHSU Knight Cancer Institute
Dec 1, 2021